Protara Therapeutics (TARA) Accumulated Depreciation (2013 - 2025)
Protara Therapeutics (TARA) posted quarterly Accumulated Depreciation of $1.5 million for Q4 2025, up 32.73% year-over-year from $1.1 million in Q4 2024, and up 32.73% quarter-over-quarter from $1.1 million in Q4 2024.
Protara Therapeutics (TARA) Accumulated Depreciation (2013 - 2025) Analysis & Trends
Protara Therapeutics (TARA) has reported Accumulated Depreciation for 10 consecutive years, with $1.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 32.73% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (up 32.73% YoY), while the FY2025 annual figure was $1.5 million, up 32.73% from the prior year.
- Accumulated Depreciation improved to $1.5 million in Q4 2025 per TARA's latest filing, from $1.1 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $1.5 million in Q4 2025 and bottomed at $824000.0 in Q4 2023.
- Historically, Accumulated Depreciation has averaged $1.1 million across 3 years, with a median of $1.1 million in 2024.
- Annual changes were most pronounced in 2024 — Accumulated Depreciation jumped 34.22% — and 2025, when it surged 32.73%.
- Protara Therapeutics' Accumulated Depreciation stood at $824000.0 in 2023, then surged by 34.22% to $1.1 million in 2024, then soared by 32.73% to $1.5 million in 2025.
- Business Quant data shows TARA's Accumulated Depreciation at $1.5 million in Q4 2025, $1.1 million in Q4 2024, and $824000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Protara Therapeutics | 234.56 Mn | 234.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 824,000.00 |
| Jun 30, 2019 | 1.02 Mn |
| Mar 31, 2019 | 1.00 Mn |
| Dec 31, 2018 | 827,000.00 |
| Dec 31, 2017 | 712,000.00 |
| Dec 31, 2016 | 565,000.00 |
| Dec 31, 2015 | 441,000.00 |
| Dec 31, 2014 | 384,000.00 |
| Dec 31, 2013 | 354,000.00 |